ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Insights, Forecast to 2029
Published Date: September 2023
|
Report Code: QYRE-Auto-7B12532
Home | Market Reports | Health| Health Conditions| Sleep Disorders
Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Research Report 2022
BUY CHAPTERS

Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Insights, Forecast to 2029

Code: QYRE-Auto-7B12532
Report
September 2023
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lanaform
Compass Health Brands (Carex Health)
Compumedics ltd
Natus Medical
Teva Pharmaceuticals
Lucimed (Luminette)
Garmin Limited
Koninklijke Philips
Mylan NV
Fitbit
Takeda Pharmaceutical
F.Hoffman La-Roche AG
Merck& Co. Inc
Pfizer Inc
PERNIX Therapeutics
Sanofi
Sumitomo Dainippon Pharma Co Ltd
Vanda Pharmaceuticals, Inc.
Compass Health Brands (Carex Health)
Lucimed (Luminette)
F.Hoffman La-Roche AG
Merck& Co. Inc
Vanda Pharmaceuticals, Inc.

Sleeplessness and Circadian Rhythm Disorder Treatment Market

Market Analysis and Insights: Global Sleeplessness and Circadian Rhythm Disorder Treatment Market
The global Sleeplessness and Circadian Rhythm Disorder Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Sleeplessness and Circadian Rhythm Disorder Treatment include Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips and Mylan, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Sleeplessness and Circadian Rhythm Disorder Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Sleeplessness and Circadian Rhythm Disorder Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sleeplessness and Circadian Rhythm Disorder Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sleeplessness and Circadian Rhythm Disorder Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Sleeplessness and Circadian Rhythm Disorder Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Sleeplessness and Circadian Rhythm Disorder Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips and Mylan, etc.

Scope of Sleeplessness and Circadian Rhythm Disorder Treatment Market Report

Report Metric Details
Report Name Sleeplessness and Circadian Rhythm Disorder Treatment Market
Segment by Type
  • Drug Therapy
  • Light Therapy
Segment by Application
  • Hospital
  • Specialist Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips, Mylan, Fitbit, Takeda Pharmaceutical, F.Hoffman La-Roche AG, Merck & Co. Inc., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd, Vanda Pharmaceuticals, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Sleeplessness and Circadian Rhythm Disorder Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sleeplessness and Circadian Rhythm Disorder Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sleeplessness and Circadian Rhythm Disorder Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Sleeplessness and Circadian Rhythm Disorder Treatment Market report?

Ans: The main players in the Sleeplessness and Circadian Rhythm Disorder Treatment Market are Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips, Mylan, Fitbit, Takeda Pharmaceutical, F.Hoffman La-Roche AG, Merck & Co. Inc., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd, Vanda Pharmaceuticals, Inc.

What are the Application segmentation covered in the Sleeplessness and Circadian Rhythm Disorder Treatment Market report?

Ans: The Applications covered in the Sleeplessness and Circadian Rhythm Disorder Treatment Market report are Hospital, Specialist Clinic, Others

What are the Type segmentation covered in the Sleeplessness and Circadian Rhythm Disorder Treatment Market report?

Ans: The Types covered in the Sleeplessness and Circadian Rhythm Disorder Treatment Market report are Drug Therapy, Light Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Drug Therapy
1.2.3 Light Therapy
1.3 Market by Application
1.3.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Perspective (2018-2029)
2.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Growth Trends by Region
2.2.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2024-2029)
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Dynamics
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Industry Trends
2.3.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
2.3.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
2.3.4 Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sleeplessness and Circadian Rhythm Disorder Treatment by Players
3.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2018-2023)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio
3.4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2022
3.5 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment Head office and Area Served
3.6 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
3.7 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Type
4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2024-2029)
5 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Application
5.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2029)
6.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
6.2.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023)
6.2.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029)
6.2.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
6.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
6.3.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023)
6.3.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029)
6.3.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
6.4 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country
6.4.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
6.4.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2029)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
7.2.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023)
7.2.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029)
7.2.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
7.3.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023)
7.3.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029)
7.3.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
7.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country
7.4.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
7.4.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2029)
8.2 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
8.2.1 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023)
8.2.2 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029)
8.2.3 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
8.3 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
8.3.1 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023)
8.3.2 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029)
8.3.3 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2029)
9.2 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
9.2.1 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023)
9.2.2 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029)
9.2.3 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
9.3 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
9.3.1 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023)
9.3.2 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029)
9.3.3 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
9.4 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region
9.4.1 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2018-2023)
9.4.3 Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lanaform
11.1.1 Lanaform Company Details
11.1.2 Lanaform Business Overview
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.1.4 Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.1.5 Lanaform Recent Developments
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Details
11.2.2 Compass Health Brands (Carex Health) Business Overview
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.2.4 Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.2.5 Compass Health Brands (Carex Health) Recent Developments
11.3 Compumedics
11.3.1 Compumedics Company Details
11.3.2 Compumedics Business Overview
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.3.4 Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.3.5 Compumedics Recent Developments
11.4 Natus Medical
11.4.1 Natus Medical Company Details
11.4.2 Natus Medical Business Overview
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.4.4 Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.4.5 Natus Medical Recent Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Developments
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Details
11.6.2 Lucimed (Luminette) Business Overview
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.6.4 Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.6.5 Lucimed (Luminette) Recent Developments
11.7 Garmin
11.7.1 Garmin Company Details
11.7.2 Garmin Business Overview
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.7.4 Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.7.5 Garmin Recent Developments
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Details
11.8.2 Koninklijke Philips Business Overview
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.8.4 Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.8.5 Koninklijke Philips Recent Developments
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.9.4 Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.9.5 Mylan Recent Developments
11.10 Fitbit
11.10.1 Fitbit Company Details
11.10.2 Fitbit Business Overview
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.10.4 Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.10.5 Fitbit Recent Developments
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Details
11.11.2 Takeda Pharmaceutical Business Overview
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.11.4 Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.11.5 Takeda Pharmaceutical Recent Developments
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Details
11.12.2 F.Hoffman La-Roche AG Business Overview
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.12.4 F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.12.5 F.Hoffman La-Roche AG Recent Developments
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Details
11.13.2 Merck & Co. Inc. Business Overview
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.13.4 Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.13.5 Merck & Co. Inc. Recent Developments
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Details
11.14.2 Pfizer, Inc. Business Overview
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.14.4 Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.14.5 Pfizer, Inc. Recent Developments
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Details
11.15.2 Pernix Therapeutics Business Overview
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.15.4 Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.15.5 Pernix Therapeutics Recent Developments
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Details
11.16.2 Sanofi S.A. Business Overview
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.16.4 Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.16.5 Sanofi S.A. Recent Developments
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Details
11.18.2 Vanda Pharmaceuticals, Inc. Business Overview
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.18.4 Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.18.5 Vanda Pharmaceuticals, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Lanaform
Compass Health Brands (Carex Health)
Compumedics ltd
Natus Medical
Teva Pharmaceuticals
Lucimed (Luminette)
Garmin Limited
Koninklijke Philips
Mylan NV
Fitbit
Takeda Pharmaceutical
F.Hoffman La-Roche AG
Merck& Co. Inc
Pfizer Inc
PERNIX Therapeutics
Sanofi
Sumitomo Dainippon Pharma Co Ltd
Vanda Pharmaceuticals, Inc.
Compass Health Brands (Carex Health)
Lucimed (Luminette)
F.Hoffman La-Roche AG
Merck& Co. Inc
Vanda Pharmaceuticals, Inc.
List of Tables
    Table 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Drug Therapy
    Table 3. Key Players of Light Therapy
    Table 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2018-2023)
    Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2024-2029)
    Table 10. Sleeplessness and Circadian Rhythm Disorder Treatment Market Trends
    Table 11. Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
    Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
    Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
    Table 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Share by Players (2018-2023)
    Table 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2022)
    Table 17. Global Sleeplessness and Circadian Rhythm Disorder Treatment Industry Ranking 2021 VS 2022 VS 2023
    Table 18. Global 5 Largest Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Headquarters and Area Served
    Table 20. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
    Table 21. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2018-2023)
    Table 25. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2024-2029)
    Table 27. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Share by Application (2018-2023)
    Table 29. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Share by Application (2024-2029)
    Table 31. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 32. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 33. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 34. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 35. North America Sleeplessness and Circadian Rhythm Disorder Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 39. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 40. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 41. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 42. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 45. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 46. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 47. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 48. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 49. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 50. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 51. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 52. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 53. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 54. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 55. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 61. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 63. Lanaform Company Details
    Table 64. Lanaform Business Overview
    Table 65. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 66. Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 67. Lanaform Recent Developments
    Table 68. Compass Health Brands (Carex Health) Company Details
    Table 69. Compass Health Brands (Carex Health) Business Overview
    Table 70. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 71. Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 72. Compass Health Brands (Carex Health) Recent Developments
    Table 73. Compumedics Company Details
    Table 74. Compumedics Business Overview
    Table 75. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 76. Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 77. Compumedics Recent Developments
    Table 78. Natus Medical Company Details
    Table 79. Natus Medical Business Overview
    Table 80. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 81. Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 82. Natus Medical Recent Developments
    Table 83. Teva Pharmaceuticals Company Details
    Table 84. Teva Pharmaceuticals Business Overview
    Table 85. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 86. Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 87. Teva Pharmaceuticals Recent Developments
    Table 88. Lucimed (Luminette) Company Details
    Table 89. Lucimed (Luminette) Business Overview
    Table 90. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 91. Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 92. Lucimed (Luminette) Recent Developments
    Table 93. Garmin Company Details
    Table 94. Garmin Business Overview
    Table 95. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 96. Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 97. Garmin Recent Developments
    Table 98. Koninklijke Philips Company Details
    Table 99. Koninklijke Philips Business Overview
    Table 100. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 101. Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 102. Koninklijke Philips Recent Developments
    Table 103. Mylan Company Details
    Table 104. Mylan Business Overview
    Table 105. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 106. Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 107. Mylan Recent Developments
    Table 108. Fitbit Company Details
    Table 109. Fitbit Business Overview
    Table 110. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 111. Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 112. Fitbit Recent Developments
    Table 113. Takeda Pharmaceutical Company Details
    Table 114. Takeda Pharmaceutical Business Overview
    Table 115. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 116. Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 117. Takeda Pharmaceutical Recent Developments
    Table 118. F.Hoffman La-Roche AG Company Details
    Table 119. F.Hoffman La-Roche AG Business Overview
    Table 120. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 121. F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 122. F.Hoffman La-Roche AG Recent Developments
    Table 123. Merck & Co. Inc. Company Details
    Table 124. Merck & Co. Inc. Business Overview
    Table 125. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 126. Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 127. Merck & Co. Inc. Recent Developments
    Table 128. Pfizer, Inc. Company Details
    Table 129. Pfizer, Inc. Business Overview
    Table 130. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 131. Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 132. Pfizer, Inc. Recent Developments
    Table 133. Pernix Therapeutics Company Details
    Table 134. Pernix Therapeutics Business Overview
    Table 135. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 136. Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 137. Pernix Therapeutics Recent Developments
    Table 138. Sanofi S.A. Company Details
    Table 139. Sanofi S.A. Business Overview
    Table 140. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 141. Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 142. Sanofi S.A. Recent Developments
    Table 143. Sumitomo Dainippon Pharma Co., Ltd Company Details
    Table 144. Sumitomo Dainippon Pharma Co., Ltd Business Overview
    Table 145. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 146. Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 147. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
    Table 148. Vanda Pharmaceuticals, Inc. Company Details
    Table 149. Vanda Pharmaceuticals, Inc. Business Overview
    Table 150. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
    Table 151. Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 152. Vanda Pharmaceuticals, Inc. Recent Developments
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Drug Therapy Features
    Figure 4. Light Therapy Features
    Figure 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application: 2022 VS 2029
    Figure 7. Hospital Case Studies
    Figure 8. Specialist Clinic Case Studies
    Figure 9. Others Case Studies
    Figure 10. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
    Figure 11. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region: 2022 VS 2029
    Figure 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players in 2022
    Figure 15. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2022
    Figure 17. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
    Figure 19. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
    Figure 20. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2029)
    Figure 21. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 24. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
    Figure 25. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
    Figure 26. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2029)
    Figure 27. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 34. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
    Figure 35. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
    Figure 36. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
    Figure 38. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
    Figure 39. Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2018-2029)
    Figure 40. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. China Taiwan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type (2018-2029)
    Figure 48. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2029)
    Figure 50. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. GCC Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Lanaform Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 57. Compass Health Brands (Carex Health) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 58. Compumedics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 59. Natus Medical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 60. Teva Pharmaceuticals Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 61. Lucimed (Luminette) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 62. Garmin Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 63. Koninklijke Philips Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 64. Mylan Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 65. Fitbit Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 66. Takeda Pharmaceutical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 67. F.Hoffman La-Roche AG Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 68. Merck & Co. Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 69. Pfizer, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 70. Pernix Therapeutics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 71. Sanofi S.A. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 72. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 73. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sleep Disorders Healthcare Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9E20272
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Adults Sleep Aid Sound Pillow Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19X20180
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Intelligent Sleep System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-28X16922
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Sleep Service Provider Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-28O17029
Fri Oct 31 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions